General MedicationsINTRAVENOUSStandard
DETECTNET
COPPER CU-64 DOTATATE
Standard Dose
4mL (1mCi/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview DETECTNET is listed in Drugs@FDA under application 213227 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient COPPER CU-64 DOTATATE Form and strength SOLUTION;INTRAVENOUS - 4mL (1mCi/ML) Sponsor CURIUM Submission history Latest submission status date: 2021-12-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview DETECTNET is listed in Drugs@FDA under application 213227 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient COPPER CU-64 DOTATATE Form and strength SOLUTION;INTRAVENOUS - 4mL (1mCi/ML) Sponsor CURIUM Submission history Latest submission status date: 2021-12-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.